Back to Search
Start Over
Data indicate potential for Ad-IL2 cancer immunotherapy program.
- Source :
- Biotech Week; 5/12/2004, p515-517, 3p
- Publication Year :
- 2004
-
Abstract
- Details results from Transgene's phase I/II clinical trial in patients with melanoma and other solid tumors as well as results from pre-clinical experiments in animal tumor models.
Details
- Language :
- English
- ISSN :
- 15352757
- Database :
- Supplemental Index
- Journal :
- Biotech Week
- Publication Type :
- Periodical
- Accession number :
- 13031832